<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>415-PHENYTOIN-(AND,-BY-EXTRAPOLATION,-FOSPHENYTOIN).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="PETHIDINE " rxcui="6754">
<ATC code="N02AB02" />
<ATC code="N02AG03" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="IRREVERSIBLE MONOAMINE OXIDASE INHIBITORS (MAOI)" code="N06AF0" /></DRUG2>
<DESCRIPTION>Risk of appearance of a serotonin syndrome: diarrhea, tachycardia, sweats, trembling, confusion, even coma</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>415-PHENYTOIN-(AND,-BY-EXTRAPOLATION,-FOSPHENYTOIN).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="PETHIDINE " rxcui="6754">
<ATC code="N02AB02" />
<ATC code="N02AG03" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="REVERSIBLE MAOI-A, INCLUDING LINEZOLIDE AND METHYLENE BLUE" code="NO6AG-001" /></DRUG2>
<DESCRIPTION>Risk of appearance of a serotonin syndrome: diarrhea, tachycardia, sweats, trembling, confusion, even coma.</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>415-PHENYTOIN-(AND,-BY-EXTRAPOLATION,-FOSPHENYTOIN).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="PETHIDINE " rxcui="6754">
<ATC code="N02AB02" />
<ATC code="N02AG03" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="MAOI-B " code="N04BD0-001" /></DRUG2>
<DESCRIPTION>Symptoms of central nervous system excitability evoking a serotonin syndrome: diarrhea, tachycardia, sweats, trembling, confusion, even coma</DESCRIPTION>
<SEVERITY>CONTRAINDICATION </SEVERITY>
</INTERACTION>
</INTERACTIONS>
